PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 10, 2025BiomedicinesOpen Access

Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo

View Full Paper
Ask AI
Bookmark
Share

Authors

IBInderjeet Singh BharajABAjit BrarAKAayushi Kacheria

Discussion

Loading...

Member takes

Overview

This review explores therapeutic strategies for cardiovascular disease and chronic kidney disease, highlighting their shared mechanisms.

Key Points

  • Therapeutic strategies improve outcomes in cardiovascular disease and chronic kidney disease by addressing key mechanisms involved in CKM syndrome.
  • Established pharmacotherapies such as SGLT2 inhibitors and GLP-1 receptor agonists significantly reduce cardiovascular events and renal decline.
  • Emerging treatments targeting lipoprotein(a) and novel RNA-based therapies show promise in the management of CKM syndrome.
  • Artificial intelligence has the potential to enhance personalized management of cardiovascular and metabolic conditions.

Cite This Study

Bharaj et al. (2025) studied this question.

synapsesocial.com/papers/68c23d3ab210217d6478cf4dhttps://doi.org/10.3390/biomedicines13092192
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 1Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction2019 · 7,128 citations